David C. Hanley
CHIEF TECHNICAL OPERATIONS · Nuvation Bio Inc.
- 2025
- Mar 4, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David C. Hanley files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gary Hattersley - $3.88M in NUVB purchases and sales in the last 12 months
- Dongfang Liu - $1.87M in NUVB purchases and sales in the last 12 months
- Kerry Wentworth - $1.47M in NUVB purchases and sales in the last 12 months
- Stacy Markel - $753K in NUVB purchases and sales in the last 12 months
- Philippe Sauvage - $286K in NUVB purchases and sales in the last 12 months
- Robert Mashal - $118K in NUVB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David C. Hanley?
David C. Hanley is a corporate insider, tracked as CHIEF TECHNICAL OPERATIONS of Nuvation Bio Inc. (NUVB). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did David C. Hanley last file a Form 4?
The most recent primary Form 4 on record is dated 4 March 2026, one of 2 filings going back to 2025.
Has David C. Hanley been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($1.43M) across all tracked filings.
